ADMAADMA Biologics, Inc.

ADMA Stock Price, Valuation & Chart | ADMA Biologics, Inc.

Compare

$9.510+0.18 (+1.93%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ADMA intrinsic value ADMA calculated fair value vs price

Overview Financials Dividends Ratios

ADMA Historical price chart

ADMA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.20B

PE Ratio13.39

EPS0.71

Trading Volume1.99M

Today's High/Low9.63/9.32

Dividend Yield0.00

52 Week High/Low20.46/7.21

Shares Outstanding231.77M

ADMA Financial Statement

ADMA Analyst ratings

ADMA Analysis & performance metrics

ADMA Company profile

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune…

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV,…

ADMA Management team

Name

Position

Adam S. GrossmanCEO

Co-Founder, President, Chief Executive Officer & Director

Brad TadeCFO

Chief Financial Officer & Treasurer

Kaitlin KestenbergCOO

Chief Operating Officer & Senior Vice President of Compliance

Michael Goldstein

General Counsel

Drew Pantello

Vice President of Marketing & Corporate Development

Cindy Petersen

Vice President of Human Resources

Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

John HaflCTO

Executive Director of Sales

Name

Position

Adam S. GrossmanCEO

Co-Founder, President, Chief Executive Officer & Director

Brad TadeCFO

Chief Financial Officer & Treasurer

Kaitlin KestenbergCOO

Chief Operating Officer & Senior Vice President of Compliance

Michael Goldstein

General Counsel

Drew Pantello

Vice President of Marketing & Corporate Development

Cindy Petersen

Vice President of Human Resources

Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

John HaflCTO

Executive Director of Sales

Management Team

Adam S. GrossmanCEO

Co-Founder, President, Chief Executive Officer & Director

Brad TadeCFO

Chief Financial Officer & Treasurer

Kaitlin KestenbergCOO

Chief Operating Officer & Senior Vice President of Compliance

Michael Goldstein

General Counsel

Drew Pantello

Vice President of Marketing & Corporate Development

Cindy Petersen

Vice President of Human Resources

Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

John HaflCTO

Executive Director of Sales

Management

Adam S. GrossmanCEO

Co-Founder, President, Chief Executive Officer & Director

Brad TadeCFO

Chief Financial Officer & Treasurer

Kaitlin KestenbergCOO

Chief Operating Officer & Senior Vice President of Compliance

Michael Goldstein

General Counsel

Drew Pantello

Vice President of Marketing & Corporate Development

Cindy Petersen

Vice President of Human Resources

Jerrold B. Grossman D.P.S., Ph.D.

Co-Founder & Vice Chairman of the Board

John HaflCTO

Executive Director of Sales

Total 8 executives

ADMA Frequently asked questions

What is ADMA Biologics, Inc. (ADMA) Stock Price?

Current stock price of ADMA Biologics, Inc. (ADMA) stock is $9.510. The stock price is +1.93% higher in the session. The intraday range can be seen from this page. Volume of ADMA Biologics, Inc. (ADMA) stock is 1.99M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the ADMA Biologics, Inc. (ADMA) stock price going up or down today?

The stock price of ADMA Biologics, Inc. (ADMA) can change with earnings, company news, and overall market sentiment. ADMA Biologics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the ADMA Biologics, Inc. stock expensive at its current price?

Whether ADMA Biologics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ADMA on this page is 13.39. EPS on this page is 0.71. Compare those figures with peers and growth expectations before deciding if the current ADMA Biologics, Inc. price is justified.

How has the stock price of ADMA Biologics, Inc. (ADMA) performed historically?

Historical performance for ADMA Biologics, Inc. (ADMA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ADMA reacted to past earnings and market events.

Should I buy ADMA Biologics, Inc. (ADMA) stock, at this price?

Buying ADMA Biologics, Inc. (ADMA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.